Announcement on Resignation of Senior Management Member
Filed with SSE · · 1 page · Chinese
Summary by 6ix AI
Tasly Pharmaceutical Group Co. Ltd. has announced the resignation of a senior management member, specifically the deputy general manager, due to personal reasons.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Tasly Pharmaceutical
- Preliminary Earnings Estimate for 2025
- Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard
- Announcement on Resolutions of the 6th Extraordinary General Meeting in 2025
- Announcement on Estimated Related Party Transactions of Daily Operations in 2026
- Announcement on Convening the Q3 2025 Performance Briefing
Later from Tasly Pharmaceutical
- Announcement on Annual Key Operating Data Report for 2025
- Announcement on Guarantee Estimate for 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Change of Accounting Policies
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical